
Targeted visceral-fat reduction and metabolic recomposition under physician care.
Price reflects the per-month rate billed across the selected term. Final eligibility and dosing are determined by your prescribing physician.
Appearance, dosage and content of the vials might actually be different for each patient based on prescription.
Billed $2,514 every 6 months for one full protocol cycle. Cancel anytime up to 48 hours before an order.
Provider prescribed. Dispensed by a licensed partner pharmacy. Created with care.
Tesamorelin is a GHRH analog prescribed for members with elevated visceral adiposity and metabolic decline. It produces a more focused effect on abdominal fat and IGF-1 than other secretagogues — and requires correspondingly closer physician supervision.
Tesamorelin stimulates pulsatile growth-hormone release with a strong downstream effect on hepatic lipid metabolism and visceral adipose tissue. It is the only GHRH analog with clinical data specifically on visceral fat reduction.
Can elevate IGF-1 — strict labs are mandatory at baseline, 90 days, and end of cycle. Not used during pregnancy, in active malignancy, with proliferative retinopathy, or with uncontrolled diabetes. Injection-site reactions are common but usually mild.
Membership is by application. Your protocol is reviewed and adjusted by a licensed physician before it ships.
Apply for membership